DWC-202301

N/A

Report date: 2024/12/30 20:00:41
NME

Base Information

Drug NameDWC-202301
Drug Alias NameDWC202301DWC-202301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co LtdiN Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A